Chronic Obstructive Pulmonary Disease
Showing NaN - NaN of 44
COPD Trial in Worldwide (Benralizumab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Benralizumab
- Placebo
-
Montgomery, Alabama
- +400 more
Jan 11, 2023
COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Itepekimab SAR440340
- Placebo
-
Palm Springs, California
- +231 more
Dec 19, 2022
COPD Trial in Worldwide (Ensifentrine, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Ensifentrine
- Placebo
-
Alabaster, Alabama
- +140 more
Nov 30, 2022
Observational Study of Obstructive Lung Disease (NOVELTY)
Active, not recruiting
- Asthma
- +2 more
- Blood draw
- +3 more
-
Loma Linda, California
- +302 more
Nov 22, 2022
COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Dupilumab SAR231893
- +4 more
-
Cullman, Alabama
- +334 more
Jun 14, 2022
COPD Trial in United States (Revefenacin, Tiotropium, Revefenacin Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Revefenacin
- +3 more
-
Jasper, Alabama
- +38 more
May 4, 2022
COPD Trial in United States (Albuterol sulfate (ABS))
Completed
- Chronic Obstructive Pulmonary Disease
- Albuterol sulfate (ABS)
-
Andalusia, Alabama
- +39 more
Nov 5, 2021
COPD, Alpha1-antitrypsin Deficiency Trial in Australia, Canada, United States (ARALAST NP 60 mg/kg, ARALAST NP 120 mg/kg,
Terminated
- Chronic Obstructive Pulmonary Disease
- Alpha1-antitrypsin Deficiency
- ARALAST NP 60 mg/kg
- +4 more
-
Peoria, Arizona
- +16 more
Apr 17, 2021
COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)
Completed
- COPD
- +2 more
- Aclidinium Bromide
- Placebo
-
Birmingham, Alabama
- +467 more
Nov 8, 2018
COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +3 more
-
Anaheim, California
- +52 more
Mar 2, 2018
COPD Trial in United States (MP-376, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- MP-376
- Placebo
-
Haleyville, Alabama
- +38 more
Jan 17, 2018
COPD Trial in United States (Aclidinium Bromide/Formoterol Fumarate, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide/Formoterol Fumarate
- Formoterol Fumarate
-
Birmingham, Alabama
- +136 more
Apr 3, 2017
COPD Trial in United States (Supplemental oxygen therapy)
Completed
- Chronic Obstructive Pulmonary Disease
- Supplemental oxygen therapy
-
Birmingham, Alabama
- +38 more
Apr 3, 2017
COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
- +3 more
-
Anniston, Alabama
- +207 more
Mar 9, 2017
COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide 200 µg
- Aclidinium Bromide 400 µg
-
Birmingham, Alabama
- +112 more
Mar 9, 2017
COPD Trial in United States (tetomilast, )
Terminated
- Chronic Obstructive Pulmonary Disease
- tetomilast
- placebo
-
Birmingham, Alabama
- +14 more
Mar 3, 2017
COPD Trial in Australia, New Zealand, United States (GFF MDI, GP MDI, FF MDI)
Completed
- Chronic Obstructive Pulmonary Disease
- GFF MDI
- +4 more
-
Andalusia, Alabama
- +139 more
Feb 7, 2017
COPD Trial in Worldwide (Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide/Formoterol Fumarate
- +3 more
-
Anniston, Alabama
- +221 more
Feb 2, 2017
COPD Trial in United States (Aclidinium 400 µg / Formoterol 12 µg, Aclidinium 400 µg / Formoterol 6 µg, Aclidinium 400 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium 400 μg / Formoterol 12 μg
- +4 more
-
Glendale, Arizona
- +19 more
Jan 16, 2017
COPD Trial in Australia, New Zealand, United States (PT005 MDI, PT001 MDI, PT003 MDI)
Completed
- Chronic Obstructive Pulmonary Disease
- PT005 MDI
- +3 more
-
Glendale, Arizona
- +19 more
Dec 7, 2016
COPD Trial in Canada, United States (Aclidinium bromide)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
-
Birmingham, Alabama
- +82 more
Nov 16, 2016
COPD Trial in Canada, United States (Aclidinium bromide, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
- Placebo
-
Birmingham, Alabama
- +111 more
Nov 16, 2016
COPD Trial in United States (PT003, PT001, PT005)
Completed
- Chronic Obstructive Pulmonary Disease
- PT003
- +3 more
-
Glendale, Arizona
- +18 more
May 23, 2016
Chronic Obstructive Pulmonary Disease Activity: Serotonin
Unknown status
- Chronic Obstructive Pulmonary Disease
-
San Antonio, Texas
- +3 more
Dec 1, 2015
COPD Trial in United States (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
*See Various Dept.'s*, Arizona
- +58 more
Mar 9, 2015